These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36016268)

  • 1. Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of
    Oliveira ES; Tavares NC; Colombarolli SG; Batista ICA; Nascimento CS; Felgner PL; de Assis RR; Calzavara-Silva CE
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil.
    Gonçalves AP; Almeida LT; Rezende IMd; Fradico JRB; Pereira LS; Ramalho DB; Pascoal Xavier MA; Calzavara Silva CE; Monath TP; LaBeaud AD; Drumond BP; Campi-Azevedo AC; Martins-Filho OA; Teixeira-Carvalho A; Alves PA;
    Microbiol Spectr; 2024 May; 12(5):e0370323. PubMed ID: 38511952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
    Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
    mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of YF-neutralizing antibodies in vulnerable populations of Brazil: A warning for epidemiological surveillance and the potential risks for future outbreaks.
    Stoffella-Dutra AG; Silva de Oliveira J; Barbosa Costa G; Geessien Kroon E; Santos Abrahão J; Desiree LaBeaud A; Paiva Drumond B; Bretas de Oliveira D; de Souza Trindade G
    Vaccine; 2020 Sep; 38(42):6592-6599. PubMed ID: 32788140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neotropical Sylvatic Mosquitoes and
    de Miranda RM; Fernandes RS; da Silva-Fernandes AT; Ferreira-de-Brito A; Moreira SB; Pereira RC; da Silva Mendes Y; de Lima SMB; Pissinatti A; Freire MDS; Alencar JAF; Lourenco-de-Oliveira R
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.
    Fernandes-Monteiro AG; Trindade GF; Yamamura AM; Moreira OC; de Paula VS; Duarte AC; Britto C; Lima SM
    Hum Vaccin Immunother; 2015; 11(7):1865-71. PubMed ID: 26011746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neighbor danger: Yellow fever virus epizootics in urban and urban-rural transition areas of Minas Gerais state, during 2017-2018 yellow fever outbreaks in Brazil.
    Sacchetto L; Silva NIO; Rezende IM; Arruda MS; Costa TA; de Mello ÉM; Oliveira GFG; Alves PA; de Mendonça VE; Stumpp RGAV; Prado AIA; Paglia AP; Perini FA; Lacerda Nogueira M; Kroon EG; de Thoisy B; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008658. PubMed ID: 33017419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.
    Kwallah Ao; Inoue S; Thairu-Muigai AW; Kuttoh N; Morita K; Mwau M
    Jpn J Infect Dis; 2015; 68(3):230-4. PubMed ID: 25672346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
    Reis LR; Costa-Rocha IAD; Campi-Azevedo AC; Peruhype-Magalhães V; Coelho-Dos-Reis JG; Costa-Pereira C; Otta DA; Freire LC; Lima SMB; Azevedo AS; Schwarcz WD; Ano Bom APD; Silva AMVD; Souza AF; Castro TDM; Ferroco CLV; Filippis AMB; Nogueira FB; Homma A; Domingues CM; Sousa ESS; Camacho LAB; Maia MLS; Teixeira-Carvalho A; Martins-Filho OA
    Vaccine; 2022 Jan; 40(5):798-810. PubMed ID: 34969545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
    Collaborative group for studies on yellow fever vaccines
    Vaccine; 2019 Aug; 37(35):5129-5135. PubMed ID: 31171393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens.
    Hassan T; Bashir RA; Abdelrahman DN; Madni H; M El Hussein AR; Elkidir IM; Enan KA
    F1000Res; 2022; 11():76. PubMed ID: 38106444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for multiple sylvatic transmission cycles during the 2016-2017 yellow fever virus outbreak, Brazil.
    Moreira-Soto A; Torres MC; Lima de Mendonça MC; Mares-Guia MA; Dos Santos Rodrigues CD; Fabri AA; Dos Santos CC; Machado Araújo ES; Fischer C; Ribeiro Nogueira RM; Drosten C; Sequeira PC; Drexler JF; Bispo de Filippis AM
    Clin Microbiol Infect; 2018 Sep; 24(9):1019.e1-1019.e4. PubMed ID: 29427798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees.
    Mateus J; Grifoni A; Voic H; Angelo MA; Phillips E; Mallal S; Sidney J; Sette A; Weiskopf D
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33198381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.
    Campi-Azevedo AC; de Araújo-Porto LP; Luiza-Silva M; Batista MA; Martins MA; Sathler-Avelar R; da Silveira-Lemos D; Camacho LA; de Menezes Martins R; de Lourdes de Sousa Maia M; Farias RH; da Silva Freire M; Galler R; Homma A; Ribeiro JG; Lemos JA; Auxiliadora-Martins M; Caldas IR; Elói-Santos SM; Teixeira-Carvalho A; Martins-Filho OA
    PLoS One; 2012; 7(12):e49828. PubMed ID: 23251351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-based sero-prevalence of chikungunya and yellow fever in the South Omo Valley of Southern Ethiopia.
    Endale A; Michlmayr D; Abegaz WE; Asebe G; Larrick JW; Medhin G; Legesse M
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008549. PubMed ID: 32881913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow Fever Virus Reemergence and Spread in Southeast Brazil, 2016-2019.
    Giovanetti M; de Mendonça MCL; Fonseca V; Mares-Guia MA; Fabri A; Xavier J; de Jesus JG; Gräf T; Dos Santos Rodrigues CD; Dos Santos CC; Sampaio SA; Chalhoub FLL; de Bruycker Nogueira F; Theze J; Romano APM; Ramos DG; de Abreu AL; Oliveira WK; do Carmo Said RF; de Alburque CFC; de Oliveira T; Fernandes CA; Aguiar SF; Chieppe A; Sequeira PC; Faria NR; Cunha RV; Alcantara LCJ; de Filippis AMB
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
    Ricciardi MJ; Rust LN; Pedreño-Lopez N; Yusova S; Biswas S; Webb GM; Gonzalez-Nieto L; Voigt TB; Louw JJ; Laurino FD; DiBello JR; Raué HP; Barber-Axthelm AM; Chun K; Uttke S; Raphael LMS; Yrizarry-Medina A; Rosen BC; Agnor R; Gao L; Labriola C; Axthelm M; Smedley J; Julander JG; Bonaldo MC; Walker LM; Messaoudi I; Slifka MK; Burton DR; Kallas EG; Sacha JB; Watkins DI; Burwitz BJ
    Sci Transl Med; 2023 Mar; 15(689):eade5795. PubMed ID: 36989376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.